Navigation Links
PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022
Date:1/15/2014

hat Induces Disease Remission 576.2.6 Improved Quality of Life for Both Patients and their Carers 586.3 Unmet Needs Gap Analysis 586.4 Opportunities 606.4.1 Increase Treatment Armamentarium for Severe Recalcitrant Patients 606.4.2 Predictive Tests for Patient Stratification 606.4.3 More Therapeutic Options that Address Patients' Pruritus 617 Pipeline Assessment 627.1 Overview 627.2 Promising Drugs in Clinical Development 647.2.1 Phase II Pipeline Products 668 Market Outlook 678.1 Global Drivers and Barriers 678.1.1 Driver: Anticipated launch of the first biologic for the treatment of moderate to severe disease 678.1.2 Driver: The underserved severe refractory patient segment presents an untapped market opportunity 688.1.3 Driver: A drug that is able to target two or more atopic diseases would gain a foothold in these markets 688.1.4 Driver: Atopic dermatitis presents an attractive patient population for drug developers 688.1.5 Driver: Restoring skin barrier function remains a key goal of disease management, meaning a continued need for moisturizers and topical agents 698.1.6 Barrier: First to second line of therapy is dominated by cheap, genericized topical drugs which create significant obstacles for novel drugs hoping to penetrate the market 708.1.7 Barrier: The largest atopic dermatitis patient segment - mild disease - can be well-controlled on most forms of topical therapy 708.1.8 Barrier: Pediatric sufferers are the largest patient group and pose a high bar in terms of safety for new products 708.1.9 Barrier: The complexity of the multiple etiologies that lead to atopic dermatitis means that treatment outcomes with existing drugs are not universal across all patient groups 718.1.10 Barrier: A significant proportion of patients experience disease remission in their early adolescent years and this may occur without drug therapy 728.2 India 738.2.1 Forecast 738.2.2 Key Events 758.2.3 Drivers and Barriers 769 Appendix 789.1 Bibliography 78
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
8. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
9. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
10. Signum Dermalogix Receives $1.6M Phase II SBIR Grant for the Development of Novel Atopic Dermatitis Therapeutics
11. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  A central ... temporary Total Artificial Heart implant is ... Hospital with the Freedom® portable driver to wait ... a 64-year-old retiree from a Syracuse architectural hardware ... the condition with medications, an implantable defibrillator and ...
(Date:7/22/2014)...  July 22, 2014 The ... Reuters , the world,s leading provider of ... announced Cortellis Clinical Trials Intelligence , ... industry-first milestone with the documentation of more ... professionals with greater and quicker access to ...
(Date:7/22/2014)... PharmaTech (Cayman) Inc. (NYSE: WX ), a leading ... in China and the ... financial results for the second quarter of 2014 after the ... (which will be Thursday morning, August 14, 2014 Shanghai time). ... section of the Company,s website at http://www.wuxiapptec.com . ...
Breaking Medicine Technology:'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
... Acute Myeloid ... ... the U.S. Food & Drug Administration (FDA) has granted orphan,drug designation ... (AML)., Celator is currently preparing to conduct two randomized Phase ...
... in ,The Lancet, and Presented at ESC Congress-, ... new international,study, the GISSI Heart Failure (GISSI-HF) study, ... esters reduced all cause mortality and hospital,admissions for ... findings are published in this week,s online version ...
Cached Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4
(Date:7/22/2014)... (PRWEB) July 23, 2014 Recently, iFitDress.com, a ... women, has announced its new selection of white party ... announced that custom made outfits are now available on its ... order before the end of July can get a discounted ... company’s products are popular among international customers, so its marketing ...
(Date:7/22/2014)... Marietta, Georgia and surrounding areas have more rescue dogs ... to lower population of needy pets; Marietta Vet Clinic, Julian ... have joined forces. Local businesses are being asked to ... presented to the Tigg Neuter Project. , The pet ... to attend and host the event. Local business as ...
(Date:7/22/2014)... Obtaining a bachelor’s degree in nursing just became ... medical experience. The School of Nursing at The University ... of an accelerated nursing degree program that provides course ... UNCG Veterans Access Program (VAP), will start January 2015 ... prior college credit, veterans who are RNs can earn ...
(Date:7/22/2014)... 22, 2014 Dr. Jeremy K. Ueno, ... colleagues, have recently discussed the reasons for an increase ... the periodontics profession are seeing the amount of referrals ... In fact, one surgeon reported that over 50% of ... dental implants have a very high success rate of ...
(Date:7/22/2014)... New York, NY (PRWEB) July 22, 2014 ... ( http://www.xareltolawsuitcenter.com/ ) that alleges the death ... bleeding caused by the blood thinner, Bernstein Liebhard LLP ... the U.S. District Court for the Southern District ... Xarelto in January 2012, and suffered a subdural hemorrhage ...
Breaking Medicine News(10 mins):Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2Health News:Marietta Vet Clinic Hosts 2014 Dog Days of Summer Pet Rescue Event 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3
... BioSpecifics,Technologies Corp. (OTC Bulletin Board: BSTC.OB), a biopharmaceutical,company ... BioSpecifics, President, Tom Wegman, will present a,corporate overview ... Healthcare,Conference on Wednesday, November 12, 2008, at 10:20am ... York, NY., A live webcast of the ...
... Nov. 7 Eric Abrue (30), a,quadriplegic patient who is ... a historic and highly successful LASIK procedure performed,by Drs. Jeffrey ... in a,playground in 1986, breaking his neck and severing his ... unable to move any,part of his body below his upper ...
... Power and Associates Also Names Kaiser Permanente "Highest ... DENVER, Nov. 7 Kaiser Permanente Colorado is ... plan in,Colorado according to a joint ranking by ... for Quality Assurance (NCQA)., To view the ...
... Study finds these doctors have better results, including survival ... heart surgeons may be the best choice for adults ... new study suggests. , A congenital heart defect occurs ... blood vessels near the heart. , The researchers analyzed ...
... Children under the age of three who had hernia surgery ... later compared to children who had not undergone the surgery, ... School of Public Health and the College of Physicians and ... into the New York State Medicaid system between 1999 and ...
... Show at Nassau Coliseum, NEW YORK, Nov. 7 ... 2009 Concert Series -- a Valentine,s Day show,with Barry Manilow, ... will be held on February 14th, 2009 at Nassau Coliseum, ... 10th at 10am,through Ticketmaster.com or by calling Stand Up for ...
Cached Medicine News:Health News:Historic LASIK Surgery Performed on Quadriplegic Patient to Preserve his Communication Abilities 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 3Health News:Pediatric Heart Surgeons May Be Best Choice for Adults 2Health News:General anesthesia for hernia surgery in children and risk of later developmental problems 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
CELL-DYN Sapphire, our flagship solution for high-volume laboratories, utilizes patented MAPSS plus 3-color fluorescent technology for improved lab efficiency....
... 2500 is a high-throughput immunoassay system built ... IMMULITE 2000 with the important addition of ... assays to be designed for optimal performance ... allows for critical assays such as the ...
... sulfate (DHEA-S) is the sulfate ester of ... enzymatic conversion of DHEA in adrenal and ... steroid secreted by the adrenal cortex, and ... biosynthesis. DHEA possesses relatively weak androgenic activity, ...
... DSL's unique DHEA-S-7kits feature ... targeted against the C-7 ... molecule, with no cross-reactivity ... Saliva RIA has been ...
Medicine Products: